Results 111 to 120 of about 3,189,503 (269)
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas +16 more
wiley +1 more source
This study explores how technological intelligence enhances the competitive advantage of Algerian start-ups. It offers new insights into how intelligent systems and processes can support decision-making and improve performance.
Zighed Rahma +4 more
doaj +1 more source
An Investigation On the Presence of Mean Reversion in Stock Prices in Tehran Stock Exchange [PDF]
Financial Scientists have always been eager to distinguish between whether the price series could be random walk (unit root) or mean reverting processes.By a random walk we mean that accruing shocks to the system have permanent impacts and prices do not ...
سعید شیرکوند +2 more
doaj
Partial inhibition of focal adhesion kinase (FAK) can paradoxically promote tumor growth, rather than simply producing a weaker antitumor effect than that observed with strong FAK suppression. In breast cancer and melanoma models, targeting p110δ PI3K, particularly in macrophages, counteracted these tumor‐promoting effects, highlighting the importance ...
Lydia Xenou +4 more
wiley +1 more source
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic +10 more
wiley +1 more source
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira +7 more
wiley +1 more source
Circulating microRNA profiles distinguish nonmalignant Lynch syndrome from cancer‐associated Lynch syndrome, sporadic colorectal cancer, and healthy controls. Age‐stratified analysis reveals disease‐specific regulatory states, and a six‐miRNA panel shows concordant separation in an independent colorectal tissue cohort.
Ramadhani Salum Chambuso +5 more
wiley +1 more source
Dynamic Interval Scheduling with Random Start and End Times
We study sequential interval scheduling with random task start and end times. Task weights and discrete start and end time distributions are given but the actual times are revealed only upon commitment; this also eliminates tasks that conflict with the committed task. The objective is to maximize the expected weight of a conflict-free schedule.
Gong, Rui, Toriello, Alejandro
openaire +2 more sources
Determinants of Fintech Fundraising in Europe
The study examines how the sub-indices of the Global Innovation Index (GII) affect the total value of fintech (financial technology) start-up fundraising in thirty-five European countries, including an eleven-country subsample from Central and Eastern ...
Katarzyna Niewińska
doaj +1 more source
Mutant p53R273H disrupts PDPK1 homodimerization and contributes to PDPK1 activation
How mutant p53R273H drives AKT signaling is unclear. We show that p53R273H, but not wild‐type, directly binds PDPK1 via a mutation‐dependent conformational change. This interaction disrupts inhibitory PDPK1 homodimerization and enhances AKT phosphorylation.
Mei Chee Lim +11 more
wiley +1 more source

